CEO Today Global Awards

www.ceotodaymagazine.com 30 CEO Today Global Awards 2019 SWITZERLAND MIHAI MANOLACHE CEO of CEBIS International FIRM PROFILE WHO WE ARE CEBIS is a Global Clinical Research Organization specialized in Clinical Research Services and Patient Support Programs. Our services support the development of pharmaceutical, biotechnology, medical devices, dietary supplements, food for particular medical purposes and phytochemicals. CEBIS has expertise in Phase II-IV clinical development studies in the following therapeutic areas: • Oncology, • Hematology, • HIV-AIDS, • CNS, • Immunology, • Hepathology-Gastroenterology, • Ob-Gyn, • UTI, • ID, • Respiratory, • Pediatric, • Dermatology, • Allergology, • Rheumatology, • Ophthalmology, • Intensive Care, • Anesthesia. CEBIS is headquartered in Switzerland and operates in 29 countries throughout Europe, India, Brazil, China and the USA, having access to a network of more than 300 research sites and more than 500 principal investigators. We offer a fullspectrum of services including in-vitro testing available across five R&D sites and in-vivo animal testing supported by a network of threeanimal research facilities. Our Vision: A global leader in patient support and treatment adherence technologies. Our Mission: Our mission is to help patients be correctly diagnosed, provide access to the best available treatments and help them to comply with the requirements foradministering their treatments ensuring high adherence. We help patients access new treatments available on the market, or new treatments under development. ABOUT MIHAI MANOLACHE Mihai Manolache is the founder of CEBIS International and holds a PhD in Biostatistics, “Carol Davila” University of Medicine and Pharmacy, Bucharest, and a Master’s Degree in Biostatistics, the University of Bucharest, Romania. Mihai completed a post-graduate course in immunology and genetics, HMX - Harvard Medical School, graduated from Law School, specializing in Medical Research Laws and Regulations, and graduated from Economics, specializing in Administrative Sciences, from the University of Bucharest. Mihai also holds a PG in Clinical Trials Management. Mihai has expertise in planning, managing and coordinating clinical studies globally. He has directed more than 200 international clinical studies including managing research sites across Romania, Bulgaria, Croatia, Hungary, Serbia and Montenegro, Macedonia, Moldova, Greece, Turkey, India, Spain, Switzerland, Italy, Germany, Ukraine, Estonia, Latvia, and Lithuania. Mihai has managed clinical trials in a variety of therapeutic areas including cardiology, oncology, diabetes, CNS, hematology, urology, gastroenterology, pediatrics, HIV, immunology, ObGyn, respiratory, and dermatology. Prior to the formation of CEBIS, Mihai was the Clinical Operations and Business Development Manager for a Global US-Based Contract Research Organization, responsible for setting up and developing clinical research business in the EMEA region. Message from the CEO At CEBIS International we keep our focus on what the patient needs. Our patient centric approach permeates throughout all our services, whether it is clinical research or our very own patient support programs. At CEBIS, we help patients access novelty treatments, whether these treatments are in the development phase, or in a post-marketing setting. We understand innovative and high-tech therapies can save a patient’s life, and we have the ability to make a significant and positive impact in improving the quality of a patient’s life. We offer a unique and tailored solution, combined with a technology approach, to help identify and support patients access and adhere to a particular therapy or device. We accomplish this by working as part of the clinical team, advancing medical science and research, and advocating and supporting patients throughout their treatment journey. We constantly strive to improve our processes to ultimately optimize patient outcomes. Our mission is to actively help patients obtain a correct diagnosis, access the best available treatment and support, to ensure high adherence for optimal clinical results and quality outcomes.